September 09, 2019 at 07:18PM FDA identifies biomarker for immune response to FVIII products used to treat hemophilia A

FDA identifies biomarker for immune response to FVIII products used to treat hemophilia A

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31jJj7n